Zura Bio Limited
Zura Bio Limited (ZURA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
zura · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$15.00
+324.9% upside
Low
$15.00
Median: $15 · Last Close: $3.53
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.35 | ↓ 5.00% |
1-day model range: $3.32–$3.39. Peak: $3.39 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ZURA · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-23 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-20 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-11-14 | Chardan Capital | Maintains | Buy→Buy |
| 2025-09-30 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-08-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-15 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-05-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-26 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Zura Bio Limited (ZURA) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover ZURA.
Analyst Recommendation Trends
ZURA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$8M
↑ 0.0% YoY
Revenue Next Year
$11M
↑ 28.6% YoY
EPS This Year
$-0.78
EPS Next Year
$-0.69
↓ 11.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ZURA EPS of $-0.78 for the current fiscal year, based on estimates from 4 analysts. The ZURA revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ZURA stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ZURA price target is $15.00 (+324.9% upside), with an analyst consensus of Buy.
The ZURA short-term stock prediction for tomorrow is $3.35 (-5.00%).
Zura Bio Limited trades on NASDAQ under the ticker ZURA. The ZURA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.
Frequently asked questions
ZURA forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month ZURA price target is $15.00, with a high forecast of $15.00 and a low of $15.00. The median price target is shown in the chart above when available. This implies +324.9% potential upside from the current price of $3.53.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.